MKI67 and neoplasm: Administration of anti-PD1 after DC activation and stromal modulation promoted selective tumor infiltration by CD8+ and proliferating Ki67+CD8+ T cells (Fig. 3b, c) without recruiting immunosuppressive Tregs (Fig. 3f) and MDSCs (Fig. 3j), therefore produced a favorable immunogenic tumor microenvironment.